data2evidence.org

What It Is

Data2Evidence is an open-source health data management and analytics platform launched by Data4Life Asia, positioned around “structured OMOP health data analysis.” It is designed for medical research scenarios, helping organizations integrate fragmented clinical data into interoperable datasets based on the OMOP Common Data Model, and then use them for exploration, cohort definition, quality control, access governance, and research analysis.

Core Capabilities

The platform centers on OMOP data standardization and research workflows. According to the crawled content, it can convert EHR, genomics, and imaging data into a unified research format, support interactive dataset browsing, assess demographics and disease prevalence, and create and manage cohorts through a visual no-code interface. Researchers can also collaborate on analysis within the platform using Python or R. On the governance side, Data2Evidence supports fine-grained roles and access permissions, data request approval workflows, and integration with existing identity governance solutions. For quality management, it provides automated data quality checks, dataset characterization, and cohort-level completeness validation.

Deployment, Ecosystem, and Documentation

Data2Evidence is clearly labeled as open source and provides GitHub, npm, and Slack entry points, which helps reduce vendor lock-in risk. Deployment is relatively flexible: it supports on-premises private data centers or cloud environments, as well as centralized or federated architectures, and it states support for compliance requirements such as GDPR and HIPAA. The documentation is fairly strong. The Quick Start includes command-level instructions for installing the d2e CLI via npm, initializing environment variables, pulling Docker images, starting services, accessing the Researcher Portal/Admin Portal, loading demo data, and stopping/cleaning up resources, making it suitable for technical teams to evaluate and validate.

Pricing, Pros, and Cons

The crawled content does not disclose pricing, paid editions, enterprise support, or payment methods, so commercial costs cannot be assessed. Its strengths are that it is open source, aligns well with the OHDSI/OMOP ecosystem, covers the full chain from data standardization to analytics and governance, and supports self-hosting. Its drawbacks are that deployment involves CLI, Docker, environment variables, certificates, and multi-component services, making it difficult for non-technical researchers to use independently; meanwhile, information on commercial support, SLAs, and production-grade security hardening is limited.

Who It’s For and Access from China

It is suitable for hospital research platforms, public health institutions, pharmacoepidemiology teams, and organizations that need standardized cross-institutional health data research. The crawled content does not provide information on access from mainland China. Ecosystem entry points such as GitHub, npm, and Slack may be unstable in China, so network connectivity, image pulling, and compliance requirements should be verified before deployment. It can be compared with OHDSI ATLAS or institution-built OMOP data analytics platforms.